Jump to content
We need you! See something you could improve? Make an edit and help improve WikSM for everyone.

Cold Induced Urticaria

From WikiSM
(Redirected from Cold Urticaria)


Other Names

  • Cold Induced Urticaria
  • Cold urticaria (ColdU)

Background

  • This page refers to cold-induced urticaria

History

  • First described by Frank in 1792[1]
  • In 1866, Bourdon reported a patient with cold Urticaria with systemic symptoms[2]

Epidemiology

  • Overall, the epidemiology is poorly defined
  • Prevalence
    • One European study estimated the prevalence at 0.05% of the population[3]
    • Prevalence is higher in Northern climates

Pathophysiology

    • Presents as pruritic wheals with or without angioedema
    • Occurs due to the release of leukotrienes, histamine and pro-inflammatory mast cell mediators after cold exposure
    • Characterized by cold-induced wheals that usually occur on rewarming and resolve within an hour
    • It is self-limited, lasting 4–5 years on average
  • Definition
    • Defined as chronic when it persists for 6 weeks or longer
    • Very little is known or understood about 'acute' cold urticaria, lasting less than 6 weeks

Etiology

Potential causes and clinical associations of cold urticaria (click to enlarge).[4]
  • Primary (no clear cause)
    • Defined when a secondary, or triggering, etiology cannot be determined
  • Secondary (associated with)
    • Bacterial and viral infections
    • Medications
    • Hymenoptera stings
    • Hematological malignancies and immunotherapy
    • Autoimmune
    • Lymphoproliferative
  • Cold Exposure
    • Critical temperature thresholds (CTT) range from below 4°C to higher than 27°C.[5]
    • Cold triggers include:
      • Contact with cold objects or surfaces
      • Cold water (eg swimming or taking cold showers)
      • Low ambient temperature (cold seasons, air conditioning)
      • Wind
      • Consumption of cold foods (ice cream, etc) and beverages
    • Often worse in winter, however no seasonal variation was noted in a study by Siebenhaar et al[6]
    • Patients typically develop symptoms within 1 to 5 minutes of exposure

Pathogenesisis

  • General
    • The cause of cold urticaria is not well understood
    • Proposed etiologies include some component of autoallergy, autoimmunity, neurogenic pathways and aberrant temperature sensing
  • Allergy
    • Cold exposure may generate auto-antigens, IgE response, mast cell degranulation and wheal formation
    • Direct evidence supporting this supporting this theory is lacking
  • Autoimmune
    • Type IIb autoimmunity with mast cell-targeting and activating autoantibodies may be involved
    • IgG auto antibodies are implicated
  • Neurogenic
  • Aberrant Temperature Sensing

Associated Conditions

  • Anaphylaxis (cold-induced anaphylaxis)
    • In one study, up to 20% of life threatening conditions presented with life threatening reactions[7]
  • Angioedema

Risk Factors

  • Demographics
    • Young adults
    • Females > Males[8]
    • Ages 20-40s

Differential Diagnosis

Clinical Features

Cold induced urticaria following ice application[9]
  • History
    • Important to clarify history, onset, trigger, etc
    • Symptoms are typically local, occur minutes after exposure
    • Systemic symptoms, anaphylaxis can develop if exposed to large surface area (i.e. swimming in cold water)
      • Constitutional: fever, fatigue
      • Skin: itchy wheals1 with or without angioedema affecting lips, tongue, pharynx
      • Respiratory: dyspnea, hoarseness, laryngeal angioedema, nasal congestion
      • Gastrointestinal: nausea, abdominal pain, diarrhoea
      • Cardiovascular: tachycardia, hypotension, shock
      • Reproductive: uterine contractions
      • CNS: headache, disorientation, fainting, vertigo
    • Sensation can be described as burning, redness, severe itching, swelling
  • Physical Exam
  • Special Tests

Evaluation

Demonstration of the Ice Cube Test and the TempTest[4]

Special Tests

  • Ice Cube Test
    • Sometimes referred to as cold stimulation testing
    • Apply melting ice cube in a thin plastic bag or non-latex medical glove to the forearm for 5 minutes
    • Test reading occurs 10 minutes after the end of cold stimulation
    • Positive test: whealing with or without itching in the contact area
    • Sensitivity is 53-83%, specificity 97-100%[10]
  • TempTest
    • Standardized testing technique which provides objective, validated and reproducible results
    • Identifies critical skin threshold and critical temperature threshold
    • Progressively lower temperatures exist along a proprietary ice pack (see images)

Laboratory

  • The provider should consider:
    • Complete Blood Count (CBC)
    • Erythrocyte Sedimentation Rate (ESR)
    • C-reactive Protein (CRP)
  • Tests to avoid
    • Cryoglobulins (present in less than 1% of cold induced urticaria)

Classification

Classification of Cold Induced Urticaria (click to enlarge)[4]
  • Cold urticaria (ColdU) is a subtype of chronic inducible urticaria
    • Can be broken down into typical vs atypical
    • See table

Management

  • Trigger avoidance
    • Cold avoidance
    • Important to measure trigger thresholds before and during any treatments to measure efficacy
    • Effectiveness of cold avoidance is limited, effect on quality of life needs to be studied
  • Lifestyle modifications
    • Recognize places with lower ambient temp (supermarket, warehouse, air conditioned rooms, ice rink, etc)
    • Precaution when traveling to caves, mountains, rivers and lakes
    • Household activities such as defrosting the freezer, cleanings windows
    • Avoid cryotherapy or cryorejuvinating procedures
    • Avoid ice cream, ice, cold fruits and vegetables, cold drinks
    • Avoid water (swimming, water polo, diving) and winter sports (hockey, figure skating, skiing, snowboarding, curling
    • Occupations (diving, butcher, sailor, fishing, polar explorer, climber, pathologist, surgeon)
  • Cold desensitization
    • Not routinely used because of the risk of Cold Agglutination, patient noncompliance, rapid and marked loss of effect in the absence of regular cold exposure.

Medications

  • Second Generation Antihistamines
    • Considered first (normal dose) and second line (high dose) treatment
    • Increasing dose above recommended appears to help control symptoms[11]
    • Take before known or expected exposure
    • About 20% of patients do not show any response, even with high doses
  • Omalizumab
    • Targets circulating IgE and affects mast cell and basophil function
    • Considered a second line agent
    • Efficacy was demonstrated in a large meta-analysis[12]
  • Epinephrine autoinjector
    • Recommended to prescribe to patients at high risk of severe symptoms[13]
  • Additional drugs that are not well studied
    • Cyclosporin
    • Tricyclic antidepressants (doxepin)
    • Immunosuppressive drugs (azathioprine, mycophenolate mofetil)
    • Cinnarizine
    • Antibiotics
    • Biological therapeutics licensed for other conditions (anakinra, etanercept, reslizumab and dupilumab) appear to have efficacy based on case reports
    • Topical Syk inhibitor and rilonacept (an interleukin 1 blocker) are in development

Rehab and Return to Play

Rehabilitation

  • Not applicable

Return to Play/ Work

  • Symptoms are usually transient
  • Can return to play once cleared by a physician
    • Important to take preventative medications before exercise or other suspected triggers
  • Return to play or sport in the event of anaphylaxis or angioedema will require careful discussion

Complications and Prognosis

Prognosis

  • Duration
    • Self limited condition which lasts 6 years on average[14]
    • Studies have suggested that only one quarter of patients will develop resolution of their symptoms within 10 years[15]
    • The disease may persist for up to 20 years
    • Predictors of longer duration include early onset, severe disease, higher temperature threshold[16]

Complications

See Also

References

  1. ↑ Frank JP. De curandis hominum morbis epitome. Mannheim, Schwan, Goetz. 1792; 3:104.
  2. ↑ Bourdon H. Note sur l’urticaire intermittente. Bull Mem Soc Hop. 1866;3:259–62.
  3. ↑ Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM. Epidemiology and clinical aspects of cold urticaria. Hautarzt. 1996;47:150.
  4. ↑ 4.0 4.1 4.2 Maltseva, Natalya, et al. "Cold urticaria–What we know and what we do not know." Allergy 76.4 (2021): 1077-1094.
  5. ↑ Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162:198-200.
  6. ↑ Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672-679.
  7. ↑ Deza G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, Pujol RM, Gimenez-Arnau AM. Acquired cold urticaria: clinical features, particular phenotypes, and disease course in a tertiary care center cohort. J Am Acad Dermatol. 2016;75(5):918–924.e912.
  8. ↑ Katsarou-Katsari A, Makris M, Lagogianni E, et al. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol. 2008;2008(22):1405.
  9. ↑ Huissoon, Aarnoud, and Mamidipudi Thirumala Krishna. "Cold-induced urticaria." New England Journal of Medicine 358.8 (2008): e9.
  10. ↑ Holm JG, Agner T, Thomsen SF. Diagnostic properties of provocation tests for cold, heat, and delayed-pressure urticaria. Eur J Dermatol. 2017;27:406-408.
  11. ↑ Kulthanan K, Hunnangkul S, Tuchinda P, et al. Treatments of cold urticaria: a systematic review. J Allergy Clin Immunol. 2019;143:1311-1331.
  12. ↑ Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J Allergy Clin Immunol. 2018;141:638-649.
  13. ↑ Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270-1277.
  14. ↑ Neittaanmäki H, Fraki JE, Gibson JR. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. Dermatologica. 1988;177:98-103.
  15. ↑ Jain SV, Mullins RJ. Cold urticaria: a 20-year follow-up study. J Eur Acad Dermatol Venereol. 2016;30(12):2066–71.
  16. ↑ Deza G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, Pujol RM, Giménez-Arnau AM. Acquired cold urticaria: clinical features, particular phenotypes, and disease course in a tertiary care center cohort. J Am Acad Dermatol 2016;75:918-924.
Created by:
John Kiel on 30 June 2019 22:56:17
Authors:
Last edited:
16 April 2022 12:01:39
Retrieved from "https://wikism.org/w/index.php?title=Cold_Induced_Urticaria&oldid=16562"